Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1961 May;40(5):803–819. doi: 10.1172/JCI104314

STUDIES ON THE ACTION OF HAGEMAN FACTOR: EVIDENCE THAT ACTIVATED HAGEMAN FACTOR IN TURN ACTIVATES PLASMA THROMBOPLASTIN ANTECEDENT*

O D Ratnoff 1,2,†, E W Davie 1,2, D L Mallett 1,2,‡
PMCID: PMC290792  PMID: 13739760

Full text

PDF
803

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BECKER E. L. Inactivation of Hageman factor by diisopropylfluorophosphate (DFP). J Lab Clin Med. 1960 Jul;56:136–138. [PubMed] [Google Scholar]
  2. BELL W. N., ALTON H. G. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature. 1954 Nov 6;174(4436):880–881. doi: 10.1038/174880a0. [DOI] [PubMed] [Google Scholar]
  3. BIGGS R., SHARP A. A., MARGOLIS J., HARDISTY R. M., STEWART J., DAVIDSON W. M. Defects in the early stages of blood coagulation: a report of four cases. Br J Haematol. 1958 Apr;4(2):177–191. doi: 10.1111/j.1365-2141.1958.tb03848.x. [DOI] [PubMed] [Google Scholar]
  4. CUNNINGHAM L. W., Jr Molecular-kinetic properties of crystalline diisopropyl phosphoryl trypsin. J Biol Chem. 1954 Nov;211(1):13–19. [PubMed] [Google Scholar]
  5. Conley C. L., Hartmann R. C., Morse W. I., 2nd THE CLOTTING BEHAVIOR OF HUMAN "PLATELET-FREE" PLASMA: EVIDENCE FOR THE EXISTENCE OF A "PLASMA THROMBOPLASTIN". J Clin Invest. 1949 Mar;28(2):340–352. doi: 10.1172/JCI102077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. ELLIS S., SIMPSON M. E. The chromatography of growth hormone on cellulose derivatives. J Biol Chem. 1956 Jun;220(2):939–949. [PubMed] [Google Scholar]
  7. FIALA S. On the role of a protein inhibitor in the first stage of blood coagulation. Arch Int Physiol. 1951 Feb;58(4):386–411. doi: 10.3109/13813455109144971. [DOI] [PubMed] [Google Scholar]
  8. GLADNER J., LAKI K. The inhibition of thrombin by diisopropyl phosphorofluoridate. Arch Biochem Biophys. 1956 Jun;62(2):501–503. doi: 10.1016/0003-9861(56)90150-3. [DOI] [PubMed] [Google Scholar]
  9. HARDISTY R. M., MARGOLIS J. The role of Hageman factor in the initiation of blood coagulation. Br J Haematol. 1959 Apr;5(2):203–211. doi: 10.1111/j.1365-2141.1959.tb04026.x. [DOI] [PubMed] [Google Scholar]
  10. JOHNSTON C. L., Jr, FERGUSON J. H., O'HANLON F. A. Surface activation of plasma clotting: a function of Hageman factor. Proc Soc Exp Biol Med. 1958 Oct;99(1):197–201. doi: 10.3181/00379727-99-24294. [DOI] [PubMed] [Google Scholar]
  11. LANGDELL R. D., WAGNER R. H., BRINKHOUS K. M. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. J Lab Clin Med. 1953 Apr;41(4):637–647. [PubMed] [Google Scholar]
  12. LEWIS J. H., WALTERS D., DIDISHEIM P., MERCHANT W. R. Application of continuous flow electrophoresis to the study of the blood coagulation proteins and the fibrinolytic enzyme system. I. Normal human materials. J Clin Invest. 1958 Sep;37(9):1323–1331. doi: 10.1172/JCI103721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. MARGOLIS J. Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation. J Physiol. 1958 Nov 10;144(1):1–22. doi: 10.1113/jphysiol.1958.sp006082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. MARGOLIS J. Experiments on Hageman factor. Thromb Diath Haemorrh. 1960;4(Suppl):132–136. [PubMed] [Google Scholar]
  16. MARGOLIS J. Initiation of blood coagulation by glass and related surfaces. J Physiol. 1957 Jun 18;137(1):95–109. doi: 10.1113/jphysiol.1957.sp005799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. MARGOLIUS A., Jr, RATNOFF O. D. Observations on the hereditary nature of Hageman trait. Blood. 1956 Jun;11(6):565–569. [PubMed] [Google Scholar]
  18. MILLER K. D., VAN VUNAKIS H. The effect of diisopropyl fluorophosphate on the proteinase and esterase activities of thrombin and on prothrombin and its activators. J Biol Chem. 1956 Nov;223(1):227–237. [PubMed] [Google Scholar]
  19. MOUNTER L. A., SHIPLEY B. A. The inhibition of plasmin by toxic phosphorus compounds. J Biol Chem. 1958 Apr;231(2):855–861. [PubMed] [Google Scholar]
  20. RAPAPORT S. I. Evidence that glass increases plasma PTA activity. J Lab Clin Med. 1958 Oct;52(4):624–633. [PubMed] [Google Scholar]
  21. RATNOFF O. D., COLOPY J. E. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955 Apr;34(4):602–613. doi: 10.1172/JCI103109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. RATNOFF O. D. Hageman trait. Thromb Diath Haemorrh. 1960;4(Suppl):116–122. [PubMed] [Google Scholar]
  23. RATNOFF O. D., LEPOW I. H. Some properties of an esterase derived from preparations of the first component of complement. J Exp Med. 1957 Aug 1;106(2):327–343. doi: 10.1084/jem.106.2.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. RATNOFF O. D., MARGOLIUS A., Jr Hageman trait: an asymptomatic disorder of blood coagulation. Trans Assoc Am Physicians. 1955;68:149–154. [PubMed] [Google Scholar]
  25. RATNOFF O. D., ROSENBLUM J. M. Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition. Am J Med. 1958 Aug;25(2):160–168. doi: 10.1016/0002-9343(58)90023-8. [DOI] [PubMed] [Google Scholar]
  26. ROSENTHAL R. L., DRESKIN O. H., ROSENTHAL N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med. 1953 Jan;82(1):171–174. doi: 10.3181/00379727-82-20057. [DOI] [PubMed] [Google Scholar]
  27. SEIBERT R. H., MARGOLIUS A., Jr, RATNOFF O. D. Observations on hemophilia, parahemophilia, and coexistent hemophilia and parahemophilia; alterations in the platelets and the thromboplastin generation test. J Lab Clin Med. 1958 Sep;52(3):449–462. [PubMed] [Google Scholar]
  28. SISE H. S., LAVELLE S. M., BECKER R. A method for assay of Stuart factor. Proc Soc Exp Biol Med. 1957 Dec;96(3):662–664. doi: 10.3181/00379727-96-23570. [DOI] [PubMed] [Google Scholar]
  29. SOULIER J. P., WARTELLE O., MENACHE D. Caractères différentiels des facteurs Hageman et P.T.A. ; rôle du contact dans la phase initiale de la coagulation. Rev Fr Etud Clin Biol. 1958 Mar;3(3):263–267. [PubMed] [Google Scholar]
  30. SOULIER J. P., WARTELLE O., MENACHE D. Hageman trait and PTA deficiency; the role of contact of blood with glass. Br J Haematol. 1959 Jan;5(1):121–138. doi: 10.1111/j.1365-2141.1959.tb04017.x. [DOI] [PubMed] [Google Scholar]
  31. TIETZE F. Molecular-kinetic properties of crystalline trypsinogen. J Biol Chem. 1953 Sep;204(1):1–11. [PubMed] [Google Scholar]
  32. TODD M. E., PANTER G., WRIGHT I. S. Deficiency of one or more factors of unusual interest. Thromb Diath Haemorrh. 1960;4(Suppl):151–157. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES